Furthermore, downregulation of PECAM1, VWF, CDH5, CLDN5, and CLDN11 was associated with poor overall survival and progression in lung cancer, which may emphasize a critical role of EndMT in these malignancies. This evidence concerns the gene CLDN11 and lung carcinoma.